Merck KGaA (MKKGY)
35.23
+0.50
(+1.44%)
USD |
OTCM |
Mar 28, 16:00
Merck Total Liabilities (Quarterly): 24.03B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 24.03B |
September 30, 2023 | 22.88B |
June 30, 2023 | 23.92B |
March 31, 2023 | 24.43B |
December 31, 2022 | 24.16B |
September 30, 2022 | 22.21B |
June 30, 2022 | 23.70B |
March 31, 2022 | 25.94B |
December 31, 2021 | 27.11B |
September 30, 2021 | 26.86B |
June 30, 2021 | 28.30B |
March 31, 2021 | 29.20B |
December 31, 2020 | 30.48B |
September 30, 2020 | 29.63B |
June 30, 2020 | 29.01B |
March 31, 2020 | 28.83B |
December 31, 2019 | 29.01B |
September 30, 2019 | 26.13B |
June 30, 2019 | 25.01B |
March 31, 2019 | 23.63B |
December 31, 2018 | 22.48B |
September 30, 2018 | 23.70B |
June 30, 2018 | 24.20B |
March 31, 2018 | 25.98B |
December 31, 2017 | 25.86B |
Date | Value |
---|---|
September 30, 2017 | 25.96B |
June 30, 2017 | 26.32B |
March 31, 2017 | 25.51B |
December 31, 2016 | 25.59B |
September 30, 2016 | 26.64B |
June 30, 2016 | 26.89B |
March 31, 2016 | 27.89B |
December 31, 2015 | 27.58B |
September 30, 2015 | 20.53B |
June 30, 2015 | 17.83B |
March 31, 2015 | 18.34B |
December 31, 2014 | 17.28B |
September 30, 2014 | 13.88B |
June 30, 2014 | 14.00B |
March 31, 2014 | 13.43B |
December 31, 2013 | 13.46B |
September 30, 2013 | 14.23B |
June 30, 2013 | 14.67B |
March 31, 2013 | 14.66B |
December 31, 2012 | 14.85B |
September 30, 2012 | 15.12B |
June 30, 2012 | 14.14B |
March 31, 2012 | 14.45B |
December 31, 2011 | 15.06B |
September 30, 2011 | 16.24B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
22.21B
Minimum
Sep 2022
30.48B
Maximum
Dec 2020
26.22B
Average
26.04B
Median
Total Liabilities (Quarterly) Benchmarks
Affimed NV | 46.62M |
InflaRx NV | 19.48M |
MorphoSys AG | 2.186B |
BioNTech SE | 3.051B |
Immatics NV | 314.91M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 53.61B |
Shareholders Equity (Quarterly) | 29.49B |
Debt to Equity Ratio | 0.3504 |
Current Ratio | 1.425 |
Net Debt Paydown Yield | 0.15% |